Table 4.
ICOC elasticity for sub-samples
| ICOC elasticity | |||||||
|---|---|---|---|---|---|---|---|
| OP costs | IP costs | Total costs |
|||||
| OLS model | Clinics only (n = 9,437) |
-0.33 (0.007) |
* |
-1.49 (0.04) |
** |
-0.52 (0.01) |
** |
| Hospitals only (n = 16,975) |
-0.03 (0.006) |
* |
-1.68 (0.04) |
* |
-0.24 (0.007) |
* | |
| 2SLS model | Clinics only |
1.03 (0.26) |
* |
-11.62 (1.93) |
* |
-1.07 (0.31) |
* |
|
Weak Instrument (Anderson-Rubin Wald test F) |
23.3 | * | 61.46 | * | 12.54 | * | |
| Wald test for endogeneity χ2(1) | 30.56 | * | 46.68 | * | 5.75 | † | |
| Hospitals only |
0.28 (0.20) |
-3.21 (1.52) |
† |
-0.50 (0.28) |
|||
|
Weak Instrument (Anderson-Rubin Wald test F) |
2.04 | 4.45 | † | 3.21 | |||
| Wald test for endogeneity χ2(1) | 2.43 | 1.02 | 0.87 | ||||
Note: *: p-value < 0.01; †: p-value < 0.05